Focusing on breast tumors, we reported that CXCR2, CD11b or CD66b expression was not correlated to the age of patients, the histological type (ductal carcinoma versus others), the size of the tumors, or lymph node status (Table 3). This evidence concerns the gene CEACAM8 and breast neoplasm.